Cargando…
Imaging features of renal complications after crizotinib treatment for non–small-cell lung cancer: a case report
Crizotinib has been approved for the treatment of advanced ALK-positive non–small cell lung cancer. Its use is associated with the development of complex renal cysts. However, there is limited literature regarding imaging features of renal cystic disease during crizotinib therapy and its complicatio...
Autores principales: | Chan, Wan Ying, Ang, Mei-Kim, Tan, Daniel Shao Weng, Koh, Wan Lin, Kwek, Jin Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996897/ https://www.ncbi.nlm.nih.gov/pubmed/27594959 http://dx.doi.org/10.1016/j.radcr.2016.04.010 |
Ejemplares similares
-
Crizotinib in the treatment of non-small-cell lung carcinoma
por: Płużański, Adam, et al.
Publicado: (2013) -
Clinical features and outcomes of ALK rearranged non‐small cell lung cancer with primary resistance to crizotinib
por: Ma, Di, et al.
Publicado: (2019) -
Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
por: Ock, Chan-Young, et al.
Publicado: (2019) -
Renal Abscess Caused by Crizotinib: A Rare Case Report
por: Wan, Zhaojun, et al.
Publicado: (2022) -
Clinical use of crizotinib for the treatment of non-small cell lung cancer
por: Roberts, Patrick J
Publicado: (2013)